Dear Ms Lesage,
My regulatory team and me, need information about the marketing authorization for our new product against Covid-19, Paxlovid.
We wonder which procedure we have to use and which is better for marketing our product : decentralized ou centralized procedure ?
Best Regards,
Meggan Gaubert